Report cover image

Enteric Softgel Capsules Global Market Report 2025

Published Sep 10, 2025
Length 250 Pages
SKU # BRC20385555

Description

Enteric Softgel Capsules Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on enteric softgel capsules market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for enteric softgel capsules ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The enteric softgel capsules market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Type: Gelatin Capsules; Non-Gelatin Softgel Capsules

2) By Distribution Channel: Supermarkets And Hypermarkets; Pharmacy And Drug Stores; Online Stores

3) By Application: Antacid And Antiflatulent Preparations; Anti-Inflammatory Drugs; Antibiotic And Antibacterial Drugs; Cough And Cold Preparations; Health Supplements; Vitamin And Dietary Supplements; Other Therapeutic Applications

4) By End User: Pharmaceutical Companies; Nutraceutical Companies; Cosmeceutical Companies; Food Industry

Subsegments:

1) By Gelatin Capsules: Bovine Gelatin Softgel Capsules; Porcine Gelatin Softgel Capsules; Fish Gelatin Softgel Capsules

2) By Non-Gelatin Softgel Capsules: Plant-based Softgel Capsules; Vegan Softgel Capsules; Polymer-Based Softgel Capsules

Companies Mentioned: BASF SE; Thermo Fisher Scientific Inc.; United Laboratories International Inc.; Herbalife Nutrition Ltd.; Catalent Pharma Solutions Inc.; Sirio Pharma Co. Ltd.; NOW Health Group Inc.; Patheon; GELITA AG; Colorcon Inc.; Aenova Group GmbH; ProCaps Laboratories Inc.; CAPTEK Softgel International Inc.; Renown Pharmaceuticals Private Limited; Viva Pharmaceutical Inc.; Biofield Pharma Private Limited; CapsCanada Corporation; Natural Capsules Limited; Fuji Capsules Co. Ltd.; Conch Lifescience Co. Ltd.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

250 Pages
1. Executive Summary
2. CRISPR-Based Diagnostics Market Characteristics
3. CRISPR-Based Diagnostics Market Trends And Strategies
4. CRISPR-Based Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global CRISPR-Based Diagnostics Growth Analysis And Strategic Analysis Framework
5.1. Global CRISPR-Based Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global CRISPR-Based Diagnostics Market Growth Rate Analysis
5.4. Global CRISPR-Based Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global CRISPR-Based Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global CRISPR-Based Diagnostics Total Addressable Market (TAM)
6. CRISPR-Based Diagnostics Market Segmentation
6.1. Global CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Kits
Buffer Solutions
Software
Other Products
6.2. Global CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinase Polymerase Amplification (RPA)
Loop-mediated Isothermal Amplification (LAMP)
Other Techniques
6.3. Global CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Infectious Diseases
Non-Infectious Diseases
6.4. Global CRISPR-Based Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Diagnostic Centers
Biotechnology Companies
Academic And Research Institutes
Other End-Users
6.5. Global CRISPR-Based Diagnostics Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CRISPR Detection Kits
CRISPR Amplification Kits
CRISPR-Based Assay Kits
6.6. Global CRISPR-Based Diagnostics Market, Sub-Segmentation Of Buffer Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CRISPR Reaction Buffers
CRISPR Lysis Buffers
6.7. Global CRISPR-Based Diagnostics Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CRISPR Data Analysis Software
CRISPR Design Software
CRISPR Diagnostic Platforms Software
6.8. Global CRISPR-Based Diagnostics Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
CRISPR Enzymes
CRISPR Reagents
CRISPR-Based Probes
7. CRISPR-Based Diagnostics Market Regional And Country Analysis
7.1. Global CRISPR-Based Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global CRISPR-Based Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific CRISPR-Based Diagnostics Market
8.1. Asia-Pacific CRISPR-Based Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China CRISPR-Based Diagnostics Market
9.1. China CRISPR-Based Diagnostics Market Overview
9.2. China CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India CRISPR-Based Diagnostics Market
10.1. India CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan CRISPR-Based Diagnostics Market
11.1. Japan CRISPR-Based Diagnostics Market Overview
11.2. Japan CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia CRISPR-Based Diagnostics Market
12.1. Australia CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia CRISPR-Based Diagnostics Market
13.1. Indonesia CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea CRISPR-Based Diagnostics Market
14.1. South Korea CRISPR-Based Diagnostics Market Overview
14.2. South Korea CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe CRISPR-Based Diagnostics Market
15.1. Western Europe CRISPR-Based Diagnostics Market Overview
15.2. Western Europe CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK CRISPR-Based Diagnostics Market
16.1. UK CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany CRISPR-Based Diagnostics Market
17.1. Germany CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France CRISPR-Based Diagnostics Market
18.1. France CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy CRISPR-Based Diagnostics Market
19.1. Italy CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain CRISPR-Based Diagnostics Market
20.1. Spain CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe CRISPR-Based Diagnostics Market
21.1. Eastern Europe CRISPR-Based Diagnostics Market Overview
21.2. Eastern Europe CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia CRISPR-Based Diagnostics Market
22.1. Russia CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America CRISPR-Based Diagnostics Market
23.1. North America CRISPR-Based Diagnostics Market Overview
23.2. North America CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA CRISPR-Based Diagnostics Market
24.1. USA CRISPR-Based Diagnostics Market Overview
24.2. USA CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada CRISPR-Based Diagnostics Market
25.1. Canada CRISPR-Based Diagnostics Market Overview
25.2. Canada CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America CRISPR-Based Diagnostics Market
26.1. South America CRISPR-Based Diagnostics Market Overview
26.2. South America CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil CRISPR-Based Diagnostics Market
27.1. Brazil CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East CRISPR-Based Diagnostics Market
28.1. Middle East CRISPR-Based Diagnostics Market Overview
28.2. Middle East CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa CRISPR-Based Diagnostics Market
29.1. Africa CRISPR-Based Diagnostics Market Overview
29.2. Africa CRISPR-Based Diagnostics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa CRISPR-Based Diagnostics Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa CRISPR-Based Diagnostics Market, Segmentation By Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. CRISPR-Based Diagnostics Market Competitive Landscape And Company Profiles
30.1. CRISPR-Based Diagnostics Market Competitive Landscape
30.2. CRISPR-Based Diagnostics Market Company Profiles
30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Integrated DNA Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Molbio Diagnostics Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Horizon Discovery Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Beam Therapeutics Overview, Products and Services, Strategy and Financial Analysis
31. CRISPR-Based Diagnostics Market Other Major And Innovative Companies
31.1. Intellia Therapeutics Inc.
31.2. Synthego Corporation
31.3. Caribou Biosciences
31.4. Mammoth Biosciences
31.5. Verve Therapeutics
31.6. Editas Medicine
31.7. Epic Bio
31.8. Sherlock Biosciences
31.9. Addgene
31.10. VedaBio
31.11. CrisprBits
31.12. SNIPR BIOME ApS
31.13. TOLO Biotech
31.14. Intact Genomics
31.15. Agdia Inc.
32. Global CRISPR-Based Diagnostics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The CRISPR-Based Diagnostics Market
34. Recent Developments In The CRISPR-Based Diagnostics Market
35. CRISPR-Based Diagnostics Market High Potential Countries, Segments and Strategies
35.1 CRISPR-Based Diagnostics Market In 2029 - Countries Offering Most New Opportunities
35.2 CRISPR-Based Diagnostics Market In 2029 - Segments Offering Most New Opportunities
35.3 CRISPR-Based Diagnostics Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.